Technical guides and protocols for lateral flow assays.
The global lateral flow assay (LFA) market is experiencing robust growth, valued at USD 17.44 billion in 2025 and projected to reach USD 25.28 billion by 2035, expanding at a CAGR of 3.78% from 2026 to 2035 (Precedence Research). For IVD professionals, distributors, and manufacturers, understanding these market dynamics is critical for strategic planning in … Read more
The clinic of the future is decentralized and highly automated. The convergence of Point of Care Testing (POCT) hardware and Robotic Process Automation (RPA) software is making this a reality. While POCT devices deliver 15-minute diagnostic results at the patient’s side, RPA handles the backend: billing, inventory deduction, patient notifications, and follow-up scheduling. This holistic … Read more
The development of new Point of Care Testing (POCT) assays, particularly those utilizing CRISPR or Time-Resolved Fluorescence (TRF), involves analyzing massive datasets. Robotic Process Automation (RPA) accelerates this R&D cycle. Bots can automate the structuring of clinical trial data, run thousands of simulated thermal cycling scenarios, and compile research findings. By freeing scientists from data … Read more
When it comes to Rapid Diagnostic Tests (RDT) and POCT, a false positive or negative can be life-threatening. Robotic Process Automation (RPA) paired with machine vision is revolutionizing Quality Assurance (QA). Automated systems can inspect thousands of test strips per minute, identifying microscopic defects in the test and control lines that human eyes would miss. … Read more
In the highly competitive In Vitro Diagnostics (IVD) market, speed and consistency are everything. Forward-thinking manufacturers are aggressively adopting Robotic Process Automation (RPA) to handle repetitive tasks in POCT production. From assembling plastic casings to pipetting microliters of TRF reagents, RPA guarantees batch-to-batch consistency. This technological leap is the secret behind how top-tier Chinese OEM/ODM … Read more
Regulatory compliance is one of the heaviest burdens for healthcare facilities utilizing Point of Care Testing (POCT). Robotic Process Automation (RPA) is stepping in to automate the generation of compliance and calibration logs. Whenever a POCT device runs a self-test or processes a patient sample, RPA bots can autonomously format and submit the required documentation … Read more
Managing the supply chain for Point of Care Testing (POCT) reagents—especially those requiring cold chain logistics—is incredibly complex. Robotic Process Automation (RPA) is solving this challenge. Software bots can continuously monitor inventory levels, track expiration dates of sensitive diagnostic reagents, and automatically trigger reorder processes. For IVD OEM/ODM manufacturers, RPA ensures that critical materials for … Read more
The synergy between Robotic Process Automation (RPA) and Microfluidic POCT is creating a new gold standard in the IVD industry. Microfluidic chips handle the complex fluid dynamics of biological samples, while RPA systems handle the high-throughput production and automated testing of these chips during the QA phase. This combination ensures that every single microfluidic cartridge … Read more
For medical device distributors, the cost of POCT equipment is a critical factor. The adoption of Robotic Process Automation (RPA) in the manufacturing of rapid diagnostic test (RDT) readers is fundamentally changing the pricing structure. RPA streamlines the calibration of sensitive optical components, such as those used in Time-Resolved Fluorescence (TRF). This automated efficiency reduces … Read more
Point of Care Testing (POCT) delivers results in minutes, but managing that data can be a bottleneck for hospital staff. Enter Robotic Process Automation (RPA). By deploying software bots to instantly extract, validate, and upload POCT results into Electronic Health Records (EHR) systems, clinics eliminate manual data entry. This seamless integration ensures that doctors receive … Read more